Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2
NCT ID: NCT00691743
Last Updated: 2009-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
850 participants
OBSERVATIONAL
2008-03-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients
NCT00681759
Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France
NCT01211652
Risk of Uncomplicated Peptic Ulcer in the General Population
NCT01888588
The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
NCT01814943
Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France
NCT01238809
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Primary care
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Greece
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rokkas Theodoros, MD
Role: PRINCIPAL_INVESTIGATOR
Errikos Ntinan Hospital, Athens, Greece
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Agrinio, , Greece
Research Site
Alexandroupoli, , Greece
Research Site
Argostoli, , Greece
Research Site
Athens, , Greece
Research Site
Chalcis, , Greece
Research Site
Corinth, , Greece
Research Site
Drama, , Greece
Research Site
Heraklion, , Greece
Research Site
Ioannina, , Greece
Research Site
Kalamata, , Greece
Research Site
Kallikratia, , Greece
Research Site
Katerini, , Greece
Research Site
Kiato, , Greece
Research Site
Komotini, , Greece
Research Site
Kozani, , Greece
Research Site
Lamia, , Greece
Research Site
Larissa, , Greece
Research Site
Pátrai, , Greece
Research Site
Peireous, , Greece
Research Site
Pírgos, , Greece
Research Site
Preveza, , Greece
Research Site
Rethymno, , Greece
Research Site
Serres, , Greece
Research Site
Thessaloniki, , Greece
Research Site
Tripoli, , Greece
Research Site
Volos, , Greece
Research Site
Xania, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-GGR-DUM-2008/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.